Raia Drogasil (BSP:RADL3) Shares Outstanding (EOP): 1,749 Mil (As of Mar. 2026)


BSP:RADL3 Raia Drogasil SA BSP:RADL3
91 GF Score
Price R$17.07
GF Value R$29.95
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Raia Drogasil Shares Outstanding (EOP)?

Raia Drogasil BSP:RADL3 +1.13% 91 Shares Outstanding (EOP) is 1,749 Mil as of Mar. 2026. GuruFocus rates BSP:RADL3 with a GF Score™ of 91/100 and a GF Value™ of R$29.95 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Raia Drogasil's shares outstanding for the quarter that ended in Mar. 2026 was 1,749 Mil.

Raia Drogasil's quarterly shares outstanding declined from Dec. 2025 (1,782 Mil) to Mar. 2026 (1,749 Mil). It means Raia Drogasil bought back shares from Dec. 2025 to Mar. 2026 .

Raia Drogasil's annual shares outstanding increased from Dec. 2024 (1,746 Mil) to Dec. 2025 (1,782 Mil). It means Raia Drogasil issued new shares from Dec. 2024 to Dec. 2025 .


Raia Drogasil  (BSP:RADL3) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Raia Drogasil Shares Outstanding (EOP) Related Terms


Raia Drogasil Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Raia Drogasil's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raia Drogasil Shares Outstanding (EOP) Chart

Raia Drogasil Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,747.31 1,747.93 1,748.67 1,746.24 1,782.21

Raia Drogasil Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,747.26 1,747.26 1,747.26 1,782.21 1,748.54

Raia Drogasil Shares Outstanding (EOP) Competitor Comparison

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil Shares Outstanding (EOP) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Shares Outstanding (EOP) falls into.


BSP:RADL3
91GF Score
Raia Drogasil SA BSP:RADL3
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raia Drogasil Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 1,749 Mil mean?
Raia Drogasil (BSP:RADL3) has a Shares Outstanding (EOP) of 1,749 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on Raia Drogasil and its competitors.
Is Raia Drogasil's Shares Outstanding (EOP) too high?
Raia Drogasil's current Shares Outstanding (EOP) is 1,749 Mil. Overall, Raia Drogasil has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raia Drogasil's Shares Outstanding (EOP) compare to competitors?
Raia Drogasil's Shares Outstanding (EOP) of 1,749 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Healthcare Providers & Services company?
A good Shares Outstanding (EOP) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Raia Drogasil and its competitors. Raia Drogasil's current Shares Outstanding (EOP) is 1,749 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raia Drogasil stock overvalued right now?
Based on GuruFocus' analysis, Raia Drogasil (BSP:RADL3) is currently considered Significantly Undervalued. The stock's GF Value™ is R$29.95, compared to a current price of R$17.07 — trading 43% below its estimated fair value. The current Shares Outstanding (EOP) is 1,749 Mil. Raia Drogasil's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Raia Drogasil (BSP:RADL3), the current Shares Outstanding (EOP) is 1,749 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raia Drogasil (BSP:RADL3) Overvalued in 2026?

Based on GuruFocus' analysis, Raia Drogasil stock appears to be undervalued. The current stock price of R$17.07 is trading 43% below its estimated GF Value™ of R$29.95. GuruFocus considers Raia Drogasil to be Significantly Undervalued.

Key valuation signals for BSP:RADL3:

  • Shares Outstanding (EOP): 1,749 Mil
  • GF Value™: R$29.95 vs. price of R$17.07 (43% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the BSP:RADL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Raia Drogasil Business Description

Other Exchanges RADLY:USA
Address Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-900
Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.
91GF Score

Get the complete analysis for BSP:RADL3

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$17.07
Price
R$29.95
GF Value